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ABSTRACT
Background: The accurate estimation of iron deficiency is important
in planning and implementing interventions. Ferritin is recommended
as the primary measure of iron status, but interpretability is challeng-
ing in settings with infection and inflammation.
Objective:We assessed the relation between ferritin concentrations
and inflammation and malaria in preschool children (PSC) (age
range: 6–59 mo) and women of reproductive age (WRA) (age
range: 15–49 y) and investigated adjustment algorithms to account
for these effects.
Design: Cross-sectional data from 15 surveys for PSC (n = 27,865)
and 8 surveys for WRA (24,844), from the Biomarkers Reflect-
ing the Inflammation and Nutritional Determinants of Anemia
(BRINDA) project were analyzed individually and combined
with the use of a meta-analysis. Several approaches were ex-
plored to estimate depleted iron stores (ferritin concentration
,12 mg/L in PSC and ,15 mg/L in WRA) in inflammation and
malaria settings as follows: 1) increase ferritin-concentration cutoff
to ,30 mg/L; 2) exclude individuals with C-reactive protein (CRP)
concentrations .5 mg/L or a-1-acid glycoprotein (AGP) concen-
trations .1 g/L; 3) apply arithmetic correction factors; and 4) use a
regression correction approach.
Results: Depleted iron-store estimates incrementally increased as
CRP and AGP deciles decreased (4% compared with 30%, and 6%
compared with 29% from highest compared with lowest CRP deciles
for pooled PSC and WRA, respectively, with similar results for AGP).
Depending on the approach used to adjust for inflammation (CRP plus
AGP), the estimated prevalence of depleted iron stores increased by 7–
25 and 2–8 absolute median percentage points for PSC and WRA,
respectively, compared with unadjusted values. Adjustment for ma-
laria in addition to CRP and AGP did not substantially change the
estimated prevalence of depleted iron stores.
Conclusions: Our results lend support for the use of internal regression
correction to estimate the prevalence of depleted iron stores in regions
with inflammation. This approach appears to mathematically reflect
the linear relation of ferritin concentrations with acute-phase proteins.
More research is warranted to validate the proposed approaches, but
this study contributes to the evidence base to guide decisions about
how and when to adjust ferritin for inflammation. Am J Clin Nutr
2017;106(Suppl):359S–71S.
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INTRODUCTION
Iron deficiency remains an important public-health problem
primarily in women and children (1–4). Iron deficiency has been
estimated to affect 1.62 billion people worldwide, although
these figures are approximations because of limited available
estimates of iron deficiency globally (5). The accurate measurement
of iron deficiency is important in the planning and implementa-
tion of interventions and for comparisons between countries or
geographic areas.
The WHO currently recommends low ferritin concentrations
(termed depleted iron stores) as the primary measure of
population-level iron deficiency because it reflects body iron
stores, has a long history of use with well-established laboratory
methods and cutoffs, is easier to measure than more-invasive
methods (e.g., bone marrow iron), and is responsive to in-
terventions (6). However, in populations with high levels of
inflammation, ferritin concentrations not only reflect nutritional
iron but are also impacted by the acute-phase response (APR) (7).
The APR is an immunologic process that causes certain acute-
phase proteins (APPs) in the body to rise or fall in response to
microbial invasion, tissue injury, immunologic reactions, and
inflammatory processes (8). In addition to its role as a marker of
iron stores, ferritin is a positive APP that becomes elevated during
an APR. In an inflammatory state, ferritin synthesis appears to
be upregulated by cytokines independent of iron homeostasis
(9, 10). Ferritin concentrations may also increase in the pres-
ence of malaria infection potentially because of impaired iron
incorporation or malaria-associated inflammation (11–13).
Thus, not accounting for changes in the control mechanisms of iron
during states of inflammation or malaria infection may translate
to a significant underestimate of depleted iron stores (7, 14).
Interest has emerged in methods to account for inflammation
andmalaria infection in the interpretation of iron biomarkers (15–
18). Because it is not possible to determine the level of inflam-
mation in apparently healthy people with the use of clinical signs
or symptoms, the WHO has recommended measuring other
APPs, namely C-reactive protein (CRP) and a-1-acid glyco-
protein (AGP), concurrently with ferritin to confirm the presence
of an APR (6). The WHO has suggested measuring both of these
biomarkers (6) because they reflect different stages of the APR (15).
Several approaches have been proposed about how to use CRP
and AGP to account for inflammation and infections such as
malaria to increase the sensitivity of detecting depleted iron
stores at the population level (14, 16, 17). These approaches
include 1) increasing the ferritin-concentration cutoff to ,30 mg/L
for the entire sample or only in individuals with elevated in-
flammation (practitioners have interpreted the WHO recommen-
dations on this approach both ways); 2) excluding individuals with
elevated inflammation; 3) applying arithmetic correction factors
(CFs); and 4) using a regression correction (RC) approach. The first
2 approaches are currently recommended by the WHO, but there
is a need to re-evaluate other approaches and reach a consensus on
how to improve the estimates of the prevalence of depleted iron
stores in populations with a high prevalence of inflammation (6).
The accurate assessment of iron deficiency is imperative to
identify populations who are most in need of iron interventions
(or not in need of additional iron) and to better understand the
contributions of iron to other conditions including anemia.
Therefore, in this article, the following 4 questions are explored:
1) Is there a need to measure biomarkers of inflammation when
measuring ferritin? 2) Is there a need to measure .1 in-
flammation biomarker (CRP and AGP) to adjust ferritin? 3) Is an
additional adjustment needed to correct ferritin concentrations in
the presence of malaria infection? and 4) How do the different
adjustment approaches for correcting for inflammation and for
calculating the estimated prevalence of depleted iron stores
compare with each other?
METHODS
We used data from the Biomarkers Reflecting Inflammation
and Nutritional Determinants of Anemia (BRINDA) project
(www.BRINDA-nutrition.org) (19). The BRINDA protocol was
reviewed by the institutional review boards of the NIH and was
deemed to be non–human subjects research. The methods for
identifying data sets, inclusion and exclusion criteria, and data
management for the BRINDA project have been described in
detail elsewhere (19). The surveys were nationally or regionally
representative, and the inclusion criteria were surveys that were
1) conducted after 2004, 2) had target groups including pre-
school children (PSC), nonpregnant women of reproductive age
(WRA), or both and 3) measured $1 marker of iron (ferritin or
soluble transferrin receptor) or vitamin A status (retinol binding
protein or retinol) and $1 marker of inflammation (AGP or
CRP). Surveys included in this analysis were those with mea-
sures of ferritin and inflammation (CRP or AGP). In all surveys
in which WRA data were collected, PSC data were also col-
lected as part of the same survey. Of the 16 PSC and 10 WRA
BRINDA data sets, data from 15 PSC and 9 WRA surveys were
applicable for analysis for this article. Malaria was measured in 5
PSC and 3 WRA data sets. Both CRP and AGP were measured in
8 of 15 PSC data sets (n = 13 surveys with CRP; n = 10 surveys
with AGP) and 4 of 9 WRA data sets (n = 9 surveys with CRP;
n = 4 surveys with AGP).
Laboratory analysis
Venous or capillary blood was collected from each respondent,
and plasma or serum was stored at 2208C until analysis; one
survey used dried blood spots. Ferritin, AGP, and CRP con-
centrations were assessed with the use of a sandwich ELISA at
the VitMin Laboratory in 8 data sets (Bangladesh, Cameroon,
Cote d’Ivoire, Laos, Liberia, Kenya 2007 and 2010, and the
Philippines) (20). Ferritin was measured with the use of an
immunoassay in 7 data sets (Colombia, Georgia, Mexico 2006
and 2012, Nicaragua, Pakistan, and the United States). CRP was
measured with the use of an immunoassay in one data set
(United States), turbidimetry in 2 data sets (Colombia, Georgia),
and nephelometry in 2 data sets (Mexico 2006 and 2012). AGP
was measuring with the use of an immunoassay in Pakistan and
turbidimetry in Nicaragua.
A comparison between the ELISA assay at the VitMin Lab-
oratory and commercially available immunoassay assays has
yielded high specificity and sensitivity and low intra-assay and
interassay variability (20). The CDC laboratory also regularly
conducts round-robin analyses to ensure comparability between
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the immunoassay and ELISA assay (D Whitehead, CDC, In-
ternational Micronutrient Malnutrition Prevention and Control
program, personal communication, 2016). In the few cases
when turbidimetry and nephelometry were used, heterogeneity
may have been of concern because of the lack of litera-
ture comparing these methods with the ELISA assay and
immunoassay.
Current malaria infection was assessed with the use of mi-
croscopy in Kenya and Coˆte d’Ivoire (21), and current or recent
malaria infection was assessed with the use of the Paracheck Pf
rapid-diagnostic test (Orchid Biomedical System) in Liberia and
histidine-rich protein 2 (Cellabs Pty Ltd.) in Cameroon. A
standardizing malaria diagnostic was not used because a sensi-
tivity analysis showed a minimal impact (22). The methods for
identifying data sets, inclusion and exclusion criteria, and data
management for the BRINDA project have been described in the
methodologic overview in this supplement, which is an open
access publication (23).
Case definitions
Depleted iron stores were defined as concentrations of ferritin
,12 mg/L in PSC and ,15 mg/L in WRA. The WHO-defined
concentration cutoff in the presence of inflammation of,30 mg/L
was also applied in PSC and WRA (although not currently part of
the WHO recommendations for WRA); the higher cutoff was
applied to the entire sample as well as only in individuals with
subclinical inflammation (6). Malaria infection was defined as
either positive or negative. Inflammation was defined as a CRP
concentration.5 mg/L, AGP concentration.1 g/L, or both (14).
A household socioeconomic status (SES) asset score was defined
by survey investigators who applied a principal component anal-
ysis within each survey to household characteristics and item
ownership. The poorest wealth quintile was compared with the
higher quintiles. In Georgia and the United States, where these
data were unavailable, household employment was used in
Georgia, and a poverty-index ratio of family income to family size
for the comparison of lowest to higher levels was used in the
United States. Maternal education was defined as any school
compared with no school.
Statistical analysis
Descriptive statistics were calculated with the use of STATA
12.0 software (StataCorp) and cross-checked with SAS 9.4
software (SAS Institute). Correlations between ferritin, CRP, and
AGP concentrations and malaria infection were calculated with
the use of Kendall’s t coefficient with the use of the SOMERSD
package (24). The Taylor linearization method was used to ob-
tain unbiased estimates that incorporated the sampling weight,
strata, and cluster (as applicable) when analyzing individual
surveys. To combine data, individual survey analyses, account-
ing for the complex survey design, were performed with the use
of the survey package in R 3.2.2 software (R Core Team) (25).
Individual survey estimates were combined with the use of a
meta-analysis approach with the use of the metafor package in
R 3.2.2 software (26, 27). The heterogeneity of estimates across
the surveys was assessed with the use of Cochran’s heteroge-
neity test (26, 27).
The prevalence of depleted iron stores (ferritin concentration
,12 or ,15 mg/L in WRA) was estimated without any ad-
justments to ferritin and was referred to as the unadjusted esti-
mate. The following 4 approaches were used to adjust ferritin for
inflammation and malaria: a higher ferritin-concentration cutoff
of ,30 mg/L, exclusion, CF, and RC (23).
Higher ferritin cutoff approach
The higher ferritin-cutoff adjustment approach uses a higher
ferritin-concentration cutoff of ,30 mg/L. We tried 2 different
approaches when the higher ferritin cutoff was used. We applied
the cutoff to the entire sample as well as to the subset of in-
dividuals with elevated CRP and AGP (as defined by a CRP
concentration .5 mg/L, AGP concentration .1 g/L, or both).
Exclusion approach
The exclusion approach uses the inflammation,malaria-biomarker
information, or both to exclude individuals with elevated in-
flammation (as defined by a CRP concentration .5 mg/L, AGP
concentration .1 g/L, or both) or individuals with malaria
infection from the analysis; this resulted in a smaller sample
size. We excluded these individuals and calculated the esti-
mated prevalence of depleted iron stores in the remaining
individuals.
CF approach
The CF approach, as proposed by Thurnham et al. (14), uses a
arithmetic CF. We calculated the CF by grouping inflammation
into the following 4 groups: 1) reference (both CRP concen-
tration #5 mg/L and AGP concentration #1 g/L); 2) incubation
(CRP concentration .5 mg/L and AGP concentration #1 g/L);
3) early convalescence (both CRP concentration .5 mg/L and
AGP concentration .1 g/L); and 4) late convalescence (CRP
concentration #5 mg/L and AGP concentration .1 g/L). We
also calculated the CF by grouping inflammation or malaria into
2 groups in which CRP, AGP, or malaria were used indepen-
dently. CFs were defined as the ratio of geometric means of the
reference group (nonelevated CRP, AGP, or malaria negative
depending on the grouping used) to those of the respective in-
flammation group or malaria group. CFs were calculated
based on internal survey-specific data [termed the internal
correction factor (ICF)], a previous meta-analysis with the
use of distinct data from the BRINDA data set [termed the
Thurnham correction factor (TCF)] (15), and the meta-
analyzed BRINDA data set [termed the BRINDA correction
factor (BCF)]. The CF approach was performed for CRP alone
(termed ICF-CRP, TCF-CRP, BCF-CRP), AGP alone (termed
ICF-AGP, TCF-AGP, BCF-AGP), and both CRP and AGP
(termed ICF-CRP1AGP, TCF-CRP1AGP, BCF-CRP1AGP). CFs
were further calculated for malaria with the use of the ICF
approach only.
RC approach
The RC approach uses linear regression to adjust ferritin
concentrations by the CRP and AGP concentrations on a con-
tinuous scale and malaria infection as a dichotomous variable as
defined in the BRINDAmethods article (23). Briefly, the adjusted
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ferritin equation was calculated by subtracting the influence of
CRP, AGP, and malaria as follows:
Ferritinadjusted ¼ ferritinunadjusted2 b1

CRPobs2CRPref

2 b2

AGPobs2AGPref

2 b3malaria
ð1Þ
Depending on the available data, CRP, AGP, or malaria can be
included in the model. b1 is the CRP regression coefficient, b2
is the AGP regression coefficient, b3 is the malaria regression
coefficient, obs is the observed value, and ref is the external
reference value generated to define low inflammation (the max-
imum values of the lowest CRP or AGP decile with the use of
combined BRINDA data with nonlogged reference values as
follows: CRP concentration in PSC: 0.10 mg/L; CRP concen-
tration in WRA: 0.16 mg/L; AGP concentration in PSC:
0.59 g/L; AGP concentration in WRA: 0.54 g/L). CRP, AGP,
and ferritin were all ln transformed; CRP and AGP were con-
tinuous variables, and malaria was a dichotomous variable. The
correction was only applied to individuals with ln CRP greater
than ln CRPref or ln AGP greater than ln AGPref to avoid over-
adjustments (23).
The first step in the RC approach was to ln transform ferritin,
CRP, and AGP concentrations to approximate normality on the
basis of regression diagnostics. CRP data contained values of
zero, and thus, the survey-specific lowest value was used to
replace zeros before applying the ln transformation. Second,
linear regression coefficients for CRP, AGP, malaria, or
a combination were estimated (bivariate and multivariate) with
ferritin as the outcome. A test of multicollinearity between ln
CRP and ln AGP or between malaria and ln CRP or ln AGP was
assessed on the basis of a test of tolerance (.0.1) and a variance
inflation factor (,5) to determine whether it was appropriate to
include all variables in the model. Third, an ln-CRP reference
value was subtracted from the ln-CRP value, and an ln-AGP
reference value was subtracted from ln-AGP concentrations in
the regression equation.
The RC approach is presented based on internal survey-
specific data [termed the internal regression correction (IRC)]
and the meta-analyzed BRINDA data [termed BRINDA re-
gression correction (BRC)]. An illustrative example of how to
adjust ferritin concentrations for inflammation with the use of the
IRC approach on the basis of real data from Liberia in PSC is
provided in Supplemental Figure 1. The BRC approach en-
tailed the replacement of CRP and AGP b coefficients in the
adjusted ferritin Equation 1 with the meta-analysis b coeffi-
cients. The same external reference values were used when
applying both the IRC and BRC approaches. Each of these RCs
was performed for CRP alone (termed IRC-CRP, BRC-CRP),
AGP alone (termed IRC-AGP, BRC-AGP), or both CRP and
AGP (termed IRC-CRP1AGP, BRC-CRP1AGP). The IRC was
also performed for malaria alone, malaria plus CRP alone,
malaria plus AGP alone, and malaria plus both CRP and AGP.
The BRC approach was not applied when including malaria in
TABLE 1
Age, inflammation, and malaria infection in preschool children and women of reproductive age: the BRINDA project1
Survey n Age2
CRP
concentration .5 mg/L
AGP
concentration .1 g/L
CRP concentration .5 mg/L or AGP
concentration .1 g/L Malaria
Preschool children
Bangladesh 1493 8.3 (6–11) 14.3 (11.8, 16.7) 33.4 (29.9, 36.9) 35.8 (32.2, 39.5) —
Cameroon 774 30.8 (12–59) 37.5 (32.7, 42.3) 39.3 (33.7, 45.0) 48.3 (43.1, 53.5) 25.9 (20.2, 31.5)
Colombia 3866 37.6 (12–59) 18.8 (17.1, 20.5) — — —
Coˆte d’Ivoire 733 31.7 (6–59) 40.4 (36.5, 44.3) 64.5 (60.3, 68.6) 67.5 (63.8, 71.3) 27.2 (22.3, 32.0)
Georgia 2142 36.4 (12–59) 24.7 (21.8, 27.5) — — —
Kenya 2007 888 19.9 (6–35) 27.8 (23.9, 31.7) 64.2 (60.2, 68.2) 66.0 (61.9, 70.1) 19.7 (15.8, 23.6)
Kenya 2010 843 21.4 (6–35) 34.2 (29.6, 38.7) 60.7 (56.0, 65.4) 61.9 (57.2, 66.6) 32.5 (28.4, 36.6)
Laos 481 33.1 (6–59) 16.6 (11.2, 22.1) 41.7 (33.9, 49.4) 44.0 (36.6, 51.5) —
Liberia 1434 19.9 (6–35) 29.5 (26.5, 32.5) 56.2 (52.5, 60.0) 59.1 (55.6, 62.7) 29.4 (26.2, 32.6)
Mexico 2006 1590 41.5 (12–59) 11.2 (9.0, 13.4) — — —
Mexico 2012 2538 37.5 (12–59) 11.7 (9.3, 14.1) — — —
Nicaragua 957 33.3 (6–59) — 26.9 (21.2, 32.5) — —
Pakistan 7221 27.3 (6–59) — 35.5 (34.0, 37.0) — —
Philippines 1767 15.0 (6–23) 13.9 (11.6, 16.2) 21.2 (17.7, 24.6) 26.0 (22.4, 29.5) —
United States 2003–2006 1138 37.9 (6–59) 6.0 (4.4, 7.5) — — —
Women of reproductive age
Cameroon 751 27.2 (15–49) 17.8 (14.8, 20.7) 7.2 (5.1, 9.3) 19.7 (16.6, 22.9) 15.0 (11.3, 18.6)
Colombia 9083 29.1 (15–49) 22.0 (20.8, 23.2) — — —
Coˆte d’Ivoire 816 27.6 (15–49) 19.7 (16.5, 22.8) 26.9 (23.5, 30.4) 33.7 (29.6, 37.9) 5.0 (3.4, 6.5)
Georgia 1688 32.7 (15–49) 29.5 (26.6, 32.4) — — —
Laos 816 29.3 (15–49) 7.9 (5.6, 10.2) 9.3 (7.1, 11.6) 13.9 (10.9, 16.8) —
Liberia 1875 28.6 (15–49) 14.3 (12.1, 16.4) 10.4 (8.7, 12.2) 18.5 (16.2, 20.8) 17.9 (15.3, 20.4)
Mexico 2006 3020 31.3 (15–49) 24.3 (21.8, 26.8) — — —
Mexico 2012 3612 34.0 (15–49) 20.7 (18.2, 23.3) — — —
United States 2003–2006 3183 33.5 (15–49) 25.6 (23.5, 27.7) — — —
1Values are percentages (95% CIs) unless otherwise indicated. AGP, a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and
Nutritional Determinants of Anemia; CRP, C-reactive protein.
2 All values are means (minimum to maximums in parentheses). Age is given in whole months in children and in whole years in women.
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the model because of the limited number of data sets that mea-
sured malaria.
We also tested whether potential confounders significantly
influenced the relation between ferritin and inflammation. We
added sex, age (months in PSC and years in WRA), maternal
education, and SES to the model, and the CRP and AGP slopes
that were adjusted for these confounders were extracted and used
in the adjusted ferritin equation.
Comparison of adjustments
Unadjusted and adjusted prevalence estimates of depleted iron
stores were compared with the use of McNemar’s chi-square
statistics; statistical significance was defined as P , 0.05 be-
fore applying the Bonferroni corrections to correct for multiple
comparisons (P = 0.05 O k, where k equals the number of
comparisons). To examine whether malaria infection remained
associated with estimated depleted iron stores after adjustment
for CRP and AGP, we stratified the adjusted estimated preva-
lence of depleted iron stores (ferritin concentrations adjusted
with the use of the IRC approach) by malaria status and com-
pared the prevalence of individuals with and without malaria
with the use of the adjusted Wald’s test to determine the effect of
malaria in addition to elevated APPs. It was decided a priori that
adjustments for CRP and AGP together and for CRP, AGP, and
malaria combined would be explored irrespective of the sig-
nificance between the malaria and nonmalaria estimated preva-
lences of depleted iron stores.
RESULTS
Participant characteristics
Our study samplewas restricted to participants with nomissing
values for ferritin, CRP, AGP, or malaria (in surveys that mea-
sured malaria); this resulted in a total loss of 6.4% (1901 of the
29,766) of the observations that met the BRINDA inclusion
criteria in PSC and of 3.4% (887 of 25,731) of the observations
that met the BRINDA inclusion criteria in WRA. Participants
who were excluded because of missing ferritin, CRP, AGP, or
malaria data did not differ from those who were included with
regard to sex, age, or SES (data not shown). The PSC mean age
range was 8.3–41.5 mo, and there was considerable age-range
variability notably for Bangladesh (6–11 mo), Liberia, Kenya
2007 and 2010 (6–35 mo), and the Philippines (6–23 mo),
whereas the age range in the remaining 10 surveys was from
either 6–59 mo (n = 5) or 12–59 mo (n = 5) (Table 1). In
contrast, WRA age ranged from 15 to 49 y in all surveys
with a mean age range of 27.2–34 y (Table 1). The prevalence
of inflammation varied across surveys in PSC (CRP concen-
tration .5 mg/L: 6.0–40.4%; AGP concentration .1 g/L:
21.2–64.5%) and WRA (CRP concentration .5 mg/L: 7.9–
29.5%, AGP concentration .1 g/L: 7.2–26.9%) (Table 1).
The prevalence of malaria varied by 13 percentage points
(pps) in both PSC (19.7–32.5%) and WRA (5.0–17.9%)
(Table 1).
Relation between ferritin, inflammation, and malaria
The rank correlations between the 2 markers of the APR, CRP
and AGP ranged from 0.48 to 0.63 in PSC and from 0.26 to 0.41
in WRA and were significant (P , 0.001) in all surveys (Sup-
plemental Table 1). There was a moderately positive associa-
tion between ferritin with CRP and AGP, and the strength of the
relations were similar for both APPs and across PSC surveys
(CRP range: 20.02 in Georgia to 0.44 in Kenya 2010; AGP
range: 0.04 in Pakistan to 0.44 in Kenya 2010) except between
ferritin and CRP in Georgia and between ferritin and AGP in
Pakistan. The relation between ferritin with CRP and AGP was
weaker in WRA than in PSC. The rank correlations between
malaria (defined as positive or negative) and ferritin ranged from
0.14 to 0.25 in PSC and from .20.01 to 0.07 in WRA (Sup-
plemental Table 1). The rank correlations between malaria and
CRP or AGP ranged from 0.12 to 0.27 in PSC and from 0.04 to
0.10 in WRA.
The relation between the estimated prevalence of depleted iron
stores and inflammation deciles visually appeared to follow a
linear pattern in PSC (Figure 1) and WRA (Figure 2) with the
estimated prevalence in depleted iron stores incrementally in-
creasing as the concentrations of CRP and AGP decreased. The
relation between the estimated prevalence of depleted iron stores
and inflammation declines did not vary according to whether
subjects were above or below CRP and AGP cutoffs. In the
lowest CRP decile group, the proportion of estimated depleted
iron stores (ferritin concentration ,12 mg/L) was substantially
higher (29.6%) than in the highest CRP decile group (4.2%) in
PSC; similarly, the estimated prevalence of depleted iron stores
was markedly higher in the lowest AGP decile (31.0%) than in
the highest AGP decile (8.3%). The prevalences between highest
and lowest decile of inflammation for WRA followed the same
pattern as for PSC; the estimated prevalence of depleted iron
stores (ferritin concentration ,15 mg/L) was 6.1% and 29.0%
FIGURE 1 Estimated prevalence [% (95% CI)] of depleted iron stores
in preschool children by CRP (A) and AGP (B) deciles: the Biomarkers Re-
flecting Inflammation and Nutritional Determinants of Anemia (BRINDA)
project. The analysis was restricted to countries (Bangladesh, Cameroon,
Coˆte d’Ivoire, Kenya 2007, Kenya 2010, Laos, Liberia, and Philippines) that
measured both CRP and AGP for comparability between CRP and AGP
relations with depleted iron stores. Sample size: n = 8458. Depleted iron
stores were defined as a ferritin concentration ,12 mg/L. Bold vertical lines
indicate the commonly used cutoffs for CRP and AGP. AGP, a-1-acid gly-
coprotein; CRP, C-reactive protein.
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for the highest and lowest CRP decile groups, respectively, and
7.9% and 26.0% for the highest and lowest AGP decile groups,
respectively.
CFs for ferritin, inflammation, and malaria
The geometric mean of ferritin was lowest in individuals with
no inflammation in PSC and WRA compared with in individuals
with inflammation with and without malaria (as a dichotomous
variable) (Table 2). Individuals who were stratified by malaria
status (as a dichotomous variable) and by the 4-inflammation
groups had the highest ferritin concentrations in the group with
malaria and elevated CRP and AGP in PSC but not in WRA
(Table 2). The CFs were ,1 across all group combinations
(CRP, AGP, and malaria) and surveys for both PSC and WRA.
The TCFs that were derived from a previous meta-analysis in
which all population groups were combined (incubation: 0.77;
early convalescence: 0.53; late convalescence: 0.75), were
similar to the BCFs although we showed the BCFs in PSC
(incubation: 0.68; early convalescence: 0.38; late convalescence:
0.65) were lower than in WRA (incubation: 0.66; early conva-
lescence: 0.52; late convalescence: 0.82).
RC slopes for ferritin, inflammation, and malaria
Bivariate linear regression with ln ferritin as the outcome
resulted in an unstandardized ln-CRP slope that ranged from
,20.01 (Georgia) to 0.31 (Coˆte d’Ivoire) and an ln-AGP slope
from 0.20 (Philippines) to 1.84 (Kenya 2010) in PSC (Supple-
mental Table 2). In WRA, the unstandardized ln-CRP slope
ranged from 0.06 (Colombia) to 0.19 (Mexico 2012) for CRP
and from 0.45 (Laos) to 0.71 (Cameroon and Liberia) for
AGP (Supplemental Table 3). There was no multicollinearity
between ln CRP and ln AGP or between ln CRP, ln AGP, and
malaria in the PSC and WRA models across surveys. A multi-
variate analysis of ln ferritin with both ln CRP and ln AGP in the
model generally dampened the ln-CRP slope and ln-AGP slope
in PSC and WRA (Supplemental Table 4) as did the inclusion
of malaria (data not shown).
Heterogeneity was shown between the slopes that were meta-
analyzed to obtain the external slope for the BRC approach.
The test of residual heterogeneity QE (df = 21) = 645 and QE
(df = 9) = 30 for PSC and WRA, respectively, when both CRP
and AGP were in the model. The highest degree of heterogeneity
was shown when creating a bivariate meta-analyzed AGP slope in
PSC. Although all surveys were retained in the combined analyses,
the removal of Pakistan from the model reduced the heterogeneity
from QE (df = 18) = 1779 to QE (df = 16) = 593, although it was
still significant (P , 0.001). Similarly, if Georgia was excluded
from the WRA data when creating a bivariate meta-analyzed
CRP slope, the heterogeneity changed from QE (df = 16) = 2358
to QE (df = 14) = 376. Neither Georgia nor Pakistan was in-
cluded when creating the multivariate meta-analyzed CRP and
AGP slopes because both surveys only included one marker of
inflammation.
Unadjusted prevalence of depleted iron stores
There was substantial variation in the prevalence of unadjusted
depleted iron stores (ferritin concentration,12 mg/L in PSC and
,15 mg/L in WRA) across surveys (Table 3). The prevalence
range was wider in the surveys that measured either CRP or AGP
(PSC range: 0.3–46.9%; WRA range: 1.4–27.9%) (Table 3) than
FIGURE 2 Estimated prevalence [% (95% CI)] of depleted iron stores
in women of reproductive age by CRP (A) and AGP (B) deciles: the Bio-
markers Reflecting Inflammation and Nutritional Determinants of Anemia
(BRINDA) project. The analysis was restricted to countries (Cameroon, Coˆte
d’Ivoire, Laos, and Liberia) that measured both CRP and AGP for compa-
rability between CRP and AGP relations with depleted iron stores. Sample
size: n = 4352. Depleted iron stores were defined as a ferritin concentration
,15 mg/L. Bold vertical lines indicate the commonly used cutoffs for CRP
and AGP. AGP, a-1-acid glycoprotein; CRP, C-reactive protein.
TABLE 2
Ferritin in preschool children and women of reproductive age according to
inflammation stage and malaria status: the BRINDA project1
Inflammatory stage
Malaria-endemic countries2
Malaria negative Malaria positive
n Ferritin, mg/L n Ferritin, mg/L
Preschool children
Reference 1693 16.71 (11.6, 24.0)3 201 25.97 (18.9, 35.6)
Incubation 123 24.50 (16.0, 37.5) 37 38.59 (25.4, 58.8)
Early convalescence 669 40.28 (27.2, 59.6) 666 77.81 (66.8, 90.7)
Late convalescence 992 23.22 (16.9, 32.0) 291 41.05 (32.2, 52.3)
Women of reproductive
age
Reference 2401 31.07 (26.4, 36.6) 267 34.91 (25.7, 47.4)
Incubation 230 41.07 (34.3, 49.2) 76 47.26 (32.1, 69.5)
Early convalescence 190 59.12 (52.3, 66.8) 67 59.19 (48.5, 72.2)
Late convalescence 185 40.49 (31.4, 52.3) 26 39.84 (23.8, 66.7)
1 Reference is defined as a CRP concentration #5 mg/L and AGP
concentration #1 g/L; incubation is defined as a CRP concentration .5 mg/L
and AGP concentration #1 g/L; early convalescence is defined as a CRP
concentration.5 mg/L and AGP concentration.1 g/L; and late convalescence
is defined as an AGP concentration .1 g/L and CRP concentration #5 mg/L.
AGP, a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation
and Nutritional Determinants of Anemia; CRP, C-reactive protein.
2 Surveys had to have a marker for CRP, AGP, and malaria to be in-
cluded and were as follows: Cameroon, Coˆte d’Ivoire, Kenya 2007, Kenya
2010, and Liberia (preschool children); and Cameroon, Coˆte d’Ivoire, and
Liberia (women of reproductive age).
3 Geometric mean; 95% CI in parentheses (all such values).
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in the surveys that measured both CRP and AGP (PSC range: 8.0–
38.9%; WRA range: 12.9–22.7%) (Table 3). In the surveys in
which data were available for both PSC and WRA, there was
considerable variation in terms of which target group (PSC or
WRA) had a higher prevalence of depleted iron stores (Table 3).
Adjusted estimated prevalence of depleted iron stores with
the exclusion of subjects with inflammation to adjust
ferritin for inflammation
The exclusion of PSC with elevated CRP or AGP resulted in a
substantial sample-size loss of 26–68% in PSC and 14–34% in
WRA (Table 3). In the surveys in which CRP was measured, the
greatest absolute change in the estimated prevalence of depleted
iron stores of subjects with CRP concentrations #5 mg/L
compared with that of the full population was in Kenya 2010
(an estimated prevalence of 27.4% compared with 19.2%, re-
spectively) for PSC and in Mexico 2012 (30.4% compared with
27.9%, respectively) for WRA (Table 3). In surveys in which
AGP was measured, the greatest absolute change in the esti-
mated prevalence of depleted iron stores of subjects with AGP
concentrations #1 g/L compared with that of the full population
was in Kenya 2010 (34.1% compared with 19.2%, respectively)
in PSC and in Coˆte d’Ivoire (an estimated prevalence of 16.2%
compared with 13.6%, respectively) in WRA (Table 3). The
greatest absolute change in the estimated prevalence of depleted
iron stores in subjects with CRP concentrations #5 mg/L and
AGP concentrations #1 g/L (Table 3) compared with that in the
full population was an estimated prevalence of 35.2% compared
with 19.2%, respectively (Kenya 2010), in PSC and an estimated
prevalence of 16.6% compared with 13.6%, respectively (Coˆte
d’Ivoire), in WRA (Table 3).
Adjusted estimated prevalence of depleted iron stores with
the use of CRP or AGP to adjust ferritin for inflammation
by the CF and RC adjustment approach
The estimated prevalence of depleted iron stores in PSC in-
crementally increased compared with the unadjusted prevalence
when CRP only, AGP only, and both CRP and AGP were used to
adjust ferritin concentrations in general across all surveys
and across adjustment methods (Supplemental Tables 5–11).
For example, with the use of the ICF approach, the estimated
prevalence of depleted iron stores in surveys that measured CRP
and AGP resulted in an absolute median increase of 4.6 pps
(range: 1.0–7.8 pps) when the ICF-CRP and of 5.9 pps (range:
TABLE 3
Estimated prevalence of depleted iron stores unadjusted and after excluding subjects with inflammation in preschool children and women of reproductive
age: the BRINDA project1
Survey
Unadjusted
CRP concentration
#5 mg/L2
AGP concentration
#1 g/L2
CRP concentration
#5 mg/L or AGP
concentration #1 g/L2
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Preschool children
Bangladesh 1493 8.0 (5.6, 10.3) 1280 8.9 (6.4, 11.4) 994 10.5 (7.7, 13.2) 958 10.6 (7.7, 13.5)
Cameroon 774 14.9 (12.1, 17.6) 493 20.2 (16.3, 24.1) 483 20.8 (17.0, 24.6) 411 21.6 (17.2, 26.0)
Colombia 3866 10.1 (8.8, 11.4) 3126 10.6 (9.1, 12.0) — — — —
Coˆte d’Ivoire 733 11.7 (8.9, 14.5) 429 17.1 (12.7, 21.4) 250 16.5 (11.4, 21.5) 227 18.0 (12.7, 23.4)
Georgia 2142 0.3 (,0.1, 0.5) 1646 0.1 (,0.1, 0.3) — — — —
Kenya 2007 888 38.9 (34.7, 43.0) 641 45.4 (40.8, 50.0) 318 53.1 (47.2, 59.1) 302 54.3 (48.4, 60.3)
Kenya 2010 843 19.2 (15.9, 22.6) 555 27.4 (23.1, 31.7) 331 34.1 (28.6, 39.6) 321 35.2 (29.6, 40.8)
Laos 481 16.6 (12.4, 20.7) 405 18.4 (14.1, 22.7) 287 19.2 (14.1, 24.4) 274 19.5 (14.3, 24.8)
Liberia 1434 20.4 (17.8, 23.0) 1059 26.1 (22.9, 29.3) 672 29.3 (24.9, 33.7) 633 30.6 (26.0, 35.1)
Mexico 2006 1590 23.4 (20.3, 26.6) 1412 24.9 (21.5, 28.4) — — — —
Mexico 2012 2538 13.5 (11.1, 15.9) 2276 14.8 (12.2, 17.5) — — — —
Nicaragua 957 33.2 (28.6, 37.9) — — 712 37.9 (32.8, 43.1) — —
Pakistan 7221 46.9 (45.4, 48.5) — — 4679 46.9 (45.0, 48.8) — —
Philippines 1767 26.2 (23.0, 29.4) 1500 28.8 (25.1, 32.4) 1345 30.0 (26.0, 33.9) 1274 30.8 (26.9, 34.7)
United States 2003–2006 1138 10.5 (7.9, 13.2) 1064 11.0 (8.3, 13.8) — — — —
Women of reproductive age
Cameroon 751 12.9 (10.2, 15.6) 616 13.7 (10.7, 16.8) 698 13.1 (10.2, 15.9) 602 14.0 (10.9, 17.1)
Colombia 9083 22.9 (21.8, 24.1) 7064 24.1 (22.8, 25.4) — — — —
Coˆte d’Ivoire 816 13.6 (10.7, 16.4) 660 15.3 (11.7, 18.8) 599 16.2 (12.7, 19.7) 546 16.6 (12.8, 20.5)
Georgia 1688 1.4 (0.8, 2.1) 1216 1.6 (0.8, 2.4) — — — —
Laos 816 22.7 (17.5, 27.9) 752 24.0 (18.6, 29.5) 734 22.9 (17.3, 28.4) 698 23.8 (18.0, 29.5)
Liberia 1875 17.9 (15.5, 20.3) 1603 19.9 (17.1, 22.7) 1677 19.1 (16.5, 21.6) 1520 20.0 (17.2, 22.7)
Mexico 2006 3020 27.5 (24.6, 30.3) 2268 28.5 (25.4, 31.6) — — — —
Mexico 2012 3612 27.9 (24.9, 30.9) 2823 30.4 (27.0, 33.8) — — — —
United States 2003–2006 3183 13.1 (11.4, 14.8) 2408 14.7 (12.6, 16.8) — — — —
1Depleted iron stores were defined as a ferritin concentration ,12 mg/L for preschool children and ,15 mg/L for women of reproductive age. AGP, a-1-
acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein.
2 Estimated prevalence of depleted iron stores in the subset of the sample with nonelevated inflammation.
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2.9–17.0 pps) when the ICF-AGP approach was used compared
with unadjusted values in PSC (Supplemental Table 7). The
estimated prevalence of depleted iron stores with the use of
the IRC approach compared with the unadjusted prevalence in
surveys that measured CRP and AGP resulted in a higher
absolute median increase when the IRC-CRP approach was
used (19.7 pps; range: 4.7–26.6 pps) than when the IRC-AGP
approach was used (15.9 pps; range: 7.3–31.8 pps); however,
in most individual surveys, the absolute increase was greater
when the IRC-AGP approach was used than when the IRC-
CRP approach was used in PSC (Figure 3, Supplemental
Table 10).
Similar to PSC, the estimated prevalence of depleted iron
stores in WRA increased when correcting for CRP, AGP, or both
(Supplemental Tables 5–11). However, the estimated prevalence
of depleted iron stores in WRA in surveys that measured CRP
and AGP was much lower than in PSC and showed an absolute
median increase of 1.4 pps (range: 1.0–1.7 pps) with the use of
the ICF-CRP approach and of 0.95 pps (range: 0.7–2.3 pps) with
the use of the ICF-AGP approach compared with unadjusted
values (Supplemental Table 7). The estimated prevalence of
depleted iron stores in WRA in surveys that measured CRP and
AGP showed an absolute median increase of 6.0 pps (range: 4.0–
9.5 pps) with the use of the IRC-CRP approach and of 6.1 pps
(range: 2.9–6.9 pps) with the use of the IRC-AGP approach
compared with unadjusted values (Supplemental Table 10).
Comparison of estimated prevalence of depleted iron stores
with the use of different approaches to adjust ferritin for
inflammation
The application of adjustments to ferritin concentrations, irre-
spective of the method, increased the estimated prevalence of
depleted iron stores compared with unadjusted estimates; generally,
there was a greater pp difference in PSC than in WRA (Supple-
mental Tables 5–11). The use of a higher ferritin-concentration
cutoff of ,30 mg/L for all PSC (regardless of inflammation
status) resulted in large absolute increase in estimates of de-
pleted iron stores upwards of 35 pps compared with un-
adjusted values (Supplemental Table 5). All other adjustments
that required the use of inflammation data and comparisons
between the different approaches described in this section are
limited to adjustments for both CRP and AGP. Adjustments
with the use of only CRP or AGP are shown in Supplemental
Tables 6–11.
With the use of a higher cutoff (ferritin concentration
,30 mg/L) in PSC with elevated inflammation (CRP concen-
tration .5 mg/L or AGP concentration .1 g/L) resulted in an
absolute median increase of 12.2 pps (range: 8.0–22.4 pps) in
the estimated prevalence of depleted iron stores compared with
unadjusted values (Figure 4, Supplemental Table 6) and a much
lower increase in WRA (absolute median: 3.0 pps; range: 2.1–
5.8 pps) (Figure 5, Supplemental Table 6). Prevalences that
were generated with the use of the higher cutoff in individuals
with elevated inflammation minus the prevalences that were
generated with the use of the ICF-CRP+AGP approach resulted
in a lower estimated prevalence of depleted iron stores (absolute
median difference: 25.6 pps; range: 27.1 to 2.7 pps) and, with
the use of the IRC-CRP+AGP approach, resulted in a higher
estimated prevalence of depleted iron stores (absolute median
difference: 11.7 pps; range: 21.6 to 22.7 pps) in PSC. When
nonmalaria and malaria countries were examined separately, the
IRC-CRP+AGP was similar (absolute median difference:20.8 pps;
range: 21.6 to 1 pps) to the higher cutoff that was applied to in-
dividuals with elevated inflammation in nonmalaria countries, but
not in the malaria countries (absolute median difference: 16.7 pps;
range: 11.4–22.7 pps) in PSC. The difference between the higher
cutoff in individuals with elevated inflammation resulted in a
FIGURE 3 Estimated prevalence [% (95% CI)] of depleted iron stores on the basis of internal regression correction adjusting for CRP, AGP, or both in
preschool children: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Depleted iron stores were defined as
a ferritin concentration,12 mg/L. Internal regression correction reference values were as follows: C-reactive protein =22.26 ln(mg/L) [QE (df = 10) = 439.9,
P , 0.0001]; and a-1-acid glycoprotein = 20.52 ln(g/L)] [QE (df = 10) = 584.6, P , 0.0001]. Bars without a common lowercase letter within a given survey
differ, P , 0.05 (adjusted by using Bonferroni correction). AGP, a-1-acid glycoprotein; CRP, C-reactive protein.
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lower difference (absolute median difference: = 21.4 pps; range:
20.9 to 23.2 pps) and a higher difference (absolute median
difference: 3.7 pps; range: 2.1–6.5 pps) than was shown with the
use of the ICF-CRP+AGP and IRC-CRP+AGP approaches, re-
spectively, in WRA.
When the ICF-CRP+AGP, BCF-CRP+AGP, and TCF-CRP+AGP
adjustment approaches were applied to ferritin concentrations, the
estimated prevalence of depleted iron stores increased by an absolute
median difference of 6.5 pps (range: 2.6–16.6 pps), 7.3 pps (range:
4.3–14.6 pps), and 4.0 pps (range: 1.7–9.7 pps), respectively,
FIGURE 4 Estimated prevalence [% (95% CI)] of depleted iron stores with the use of different inflammation-adjustment approaches in preschool
children: BRINDA project. Depleted iron stores were defined as a ferritin concentration,12 mg/L except in the higher-cutoff approach in which depleted iron
stores were defined as a ferritin concentration ,30 mg/L. Only surveys that measured both AGP and CRP are presented. Bars without a common lowercase
letter within a given survey differ, P , 0.05 (adjusted by using Bonferroni correction). BRINDA correction factors were as follows—incubation phase: 0.68
(95% CI: 0.60, 0.79); early convalescence phase: 0.38 (95% CI: 0.30, 0.49); and late convalescence phase: 0.65 (95% CI: 0.58, 0.74) [QE (df = 28) = 515.9,
P , 0.0001]. Internal regression correction and BRINDA regression correction reference values were as follows—CRP: 22.26 ln(mg/L) [QE (df = 10) =
439.9, P, 0.0001]; and AGP:20.52 ln(g/L) [QE (df = 10) = 584.6, P, 0.0001]. BRINDA regression correction coefficients were as follows—ln CRP = 0.12
and ln AGP = 0.71 [QE (df = 21) = 644.8, P , 0.0001]. AGP, a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional
Determinants of Anemia; CRP, C-reactive protein; -CRP+AGP, adjusting for C-reactive protein and a-1-acid glycoprotein.
FIGURE 5 Estimated prevalence [% (95% CI)] of depleted iron stores with the use of different inflammation-adjustment approaches in women of
reproductive age: BRINDA project. Depleted iron stores were defined as a ferritin concentration ,15 mg/L except in the higher-cutoff approach in which
depleted iron stores were defined as a ferritin concentration,30 mg/L. Only surveys that measured both AGP and CRP are presented. Bars without a common
lowercase letter within a given survey differ, P , 0.05 (adjusted by using Bonferroni correction). BRINDA correction factors were as follows—
incubation phase: 0.66 (95% CI: 0.53, 0.83); early convalescence phase: 0.52 (95% CI: 0.44, 0.61); and late convalescence phase: 0.82 (95% CI: 0.68,
0.99) [QE (df = 12) = 38.7, P , 0.0001]. Internal regression correction and BRINDA regression correction reference values were as follows—CRP:
21.83 ln(mg/L) [QE (df = 6) = 1142.4, P , 0.001]; and AGP-0.63 ln(g/L) [QE (df = 4) = 83.8, P , 0.0001]. BRINDA regression correction coefficients
were as follows—ln CRP = 0.11; and ln-AGP: 0.34 [QE (df = 9) = 29.6, P , 0.001]. AGP, a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting
Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; -CRP+AGP, adjusting for C-reactive protein and a-1-acid glycoprotein.
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compared with unadjusted values in PSC (Figure 4, Supplemental
Tables 7–9). In contrast, the increase in the estimated prevalence in
WRA was much lower [ICF-CRP+AGP absolute median differ-
ence: 1.6 pps (range: 1.2–2.6 pps); BCF-CRP+AGP absolute me-
dian difference: 1.6 pps (range: 1.3–2.9 pps); and TCF-CRP+AGP
absolute median difference: 1.5 pps (range: 0.8–2.7 pps)] compared
with unadjusted values (Figure 5, Supplemental Tables 7–9). The
difference between the TCF-CRP+AGP and the BCF-CRP+AGP
adjusted estimates of depleted iron stores was consistently lower
by a small amount (absolute median difference: 23 pps; range:
22.6 to 4.9 pps), although in 2 surveys (Laos and Liberia), the
difference between TCF and BCF was close to 5 pps in PSC
(Supplemental Tables 8 and 9). The difference between the
TCF-CRP+AGP and BCF-CRP+AGP approaches was negli-
gible in WRAwith a difference of ,1 pp (Supplemental Tables
8 and 9).
The use of the IRC-CRP+AGP approach to adjust ferritin
concentrations in PSC increased the estimated prevalence of
depleted iron stores by an absolute median of 24.7 pps (range:
8.1–35.6 pps) compared with unadjusted values, and the use of
the BRC-CRP+AGP approach to adjust ferritin concentrations in
PSC increased the estimated prevalence of depleted iron stores
by an absolute median of 18.0 pps (range: 16.0–31.0 pps)
compared with unadjusted values, whereas in WRA, the prev-
alences were lower with absolute medians of 7.5 pps (range:
4.5–10.7 pps) and 7.7 pps (range: 4.5–10 pps), respectively
compared with unadjusted values (Figures 4 and 5, Supple-
mental Tables 10 and 11). The comparison of differences be-
tween the use of the IRC-CRP+AGP approach compared with
the BRC-CRP+AGP approach to adjust ferritin concentrations
resulted in an absolute median difference of23.4 pps (range:216.5
to 8.8 pps) in PSC (Figure 4). The pp difference between IRC-
CRP+AGP compared with BRC-CRP+AGP approaches was
,1 pp in WRA (Figure 5, Supplemental Tables 10 and 11). The
difference between the IRC-CRP+AGP– minus the ICF-CRP+AGP–
adjusted depleted iron-store estimates was consistently higher
[absolute median differences: 15.8 pps (range: 4.6–24 pps) and
5.8 pps (range: 3.2–8.1 pps)] in PSC and WRA, respectively
(Figures 4 and 5).
Comparison of estimated prevalence of depleted iron stores
with the use of different approaches to adjust ferritin for
inflammation and malaria
Adjustment for malaria alone with the use of an ICF approach
increased the estimated prevalence of depleted iron stores by an
absolute median of 5.1 pps (range: 2.6–6.3 pps) in PSC and of
0.5 pps (range: 0–1.2 pps) in WRA (Supplemental Table 12).
After the adjustment of ferritin concentrations with the use of
the IRC-CRP+AGP approach, the estimated prevalence of de-
pleted iron stores was significantly different (P , 0.0001) in
subjects with and without malaria in 4 of 5 surveys that included
malaria in PSC and in 1 of 3 surveys that included malaria in
WRA (Figure 6, Supplemental Table 12). Adjustment of CRP
and AGP alone (IRC-CRP+AGP) resulted in similar point esti-
mates of depleted iron stores to those when adjusting for CRP
and AGP plus malaria with the use of the IRC approach [ab-
solute median differences: 20.9 pp (range: 23.9 to 0.7 pps) in
PSC and 0 pps (range: 20.3 to 0.3 pps) in WRA)] (Figure 6,
Supplemental Table 12).
Estimated prevalence of depleted iron stores with the use of
the IRC approach to adjust ferritin for inflammation
taking into account confounders
There was little difference between the prevalence of depleted
iron stores adjusting for ferritin with the use of the IRC approach
when controlling for SES, maternal education, age, and sex
(maternal education data were unavailable in Bangladesh, Liberia,
Georgia, Mexico, and the United States for PSC and in all surveys
for WRA, and SES data were unavailable in Bangladesh and
Nicaragua). The absolute median difference of adjusted depleted
iron stores controlling for confounders compared with not con-
trolling for confounders was 0.40 pps (range: 21.2 to 3.8 pps) for
IRC-CRP, 0.45 pps (range: 21.4 to 2.8 pps) for IRC-AGP, and
0.05 pps (range:21.9 to 2.5 pps) for IRC-CRP+AGP in PSC (data
not shown). The absolute median difference of depleted iron stores
compared with not controlling for these factors was 20.90 pps
(range: 23.7 to 0.2 pps) for IRC-CRP, 0.05 pps (range: 20.2 to
0.3 pps) for IRC-AGP, and 20.35 pps (range: 21.6 to 0 pps) for
IRC-CRP+AGP in WRA (data not shown).
DISCUSSION
The results of this multicountry analysis showed that in-
flammation and malaria infection affected ferritin concentrations
such that individuals with inflammation or malaria infection had a
higher ferritin concentration and were less likely to be classified
as having depleted iron stores than were subjects without in-
flammation or malaria.
In this study, the first question we sought to answer was
whether it is necessary to measure biomarkers of inflammation to
estimate the prevalence of depleted iron stores. We showed a
consistent positive correlation between ferritin with CRP and
AGP concentrations, and the strength of the association was
similar for both biomarkers; ferritin concentrations were highest
when CRP and AGP were elevated (23) as have been shown by
others (14). This finding lends support to the hypothesis that the
magnitude of change in ferritin concentrations differs depending
on the stage in the inflammatory process (18). Perhaps, more
importantly, we showed that ferritin concentrations were altered
well below the CRP and AGP cutoffs. This result indicates that
clinically defined cutoffs for CRP and AGP may have less rel-
evance when attempting to capture the influences of CRP and
AGP on ferritin concentrations (23). These results corroborate
findings by Duncan et al. (28), whereby low concentrations of
CRP effected the concentrations of micronutrient biomarkers.
Our second question was whether both CRP and AGP are
required to interpret ferritin concentrations. CRP tends to rise
quickly in response to injury or infection and has a half-life of
w2 d, whereas AGP rises slower but remains elevated with a
half-life of $5 d (18). Not surprisingly, as has been shown
elsewhere (29), adjustments with the use of both CRP and AGP
increased the estimated prevalence of depleted iron stores com-
pared with the use of either CRP or AGP alone, although AGP
frequently provided similar estimates to those when adjusting for
CRP and AGP. Nevertheless, CRP is more routinely measured
and should continue to be measured along with AGP until we
better understand the relation between ferritin, CRP, and AGP.
In answer to our third question, malaria infection was in-
dependently associated with ferritin after controlling for CRP and
AGP. This result could reflect impaired iron incorporation in
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response to malaria infection by the suppression of erythropoi-
etin (11–13). Alternatively, or in addition, it may be the effect
of residual confounding of malaria-associated inflammation
that are not fully captured by CRP or AGP (30). However,
malaria adjustments alone resulted in lower adjustments to
CRP and AGP, which were consistent with past studies (17).
When CRP and AGP are measured, there appears to be
limited utility in measuring malaria status to adjust ferritin
concentrations.
Our fourth question was to compare adjustment approaches to
estimate the prevalence of depleted iron stores in populations
with inflammation. To compare approaches, we considered the
following 3 criteria: 1) precision, 2) variability reflecting relation
between nutrient biomarkers and severity of inflammation, and
3) feasibility to implement across countries. The application
of different adjustment approaches resulted in a high degree
of variability in the estimated prevalence of depleted iron
stores. The exclusion approach resulted in a loss of precision
(averaging a 50% sample loss when excluding subjects with
elevated CRP and AGP) and may have introduced bias. The use
of a fixed ferritin-concentration cutoff of ,30 mg/L (in subjects
with elevated CRP or AGP) was relatively equivalent to the IRC
approach in nonmalaria settings, whereas in malaria settings, the
IRC approach resulted in a greater estimated prevalence of de-
pleted iron stores. The fixed higher cutoff is a crude but easy
adjustment approach, and its sensitivity and specificity should be
further assessed because it was derived from a single study in
pregnant women (1, 31, 32).
FIGURE 6 Estimated prevalence [% (95% CI)] of depleted iron stores with the use of different inflammation- and malaria-adjustment approaches in
preschool children (A) and women of reproductive age (B): Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project.
Depleted iron stores were defined as a ferritin concentration ,12 mg/L in preschool children and a ferritin concentration ,15 mg/L in women of reproductive
age. Only surveys that measured malaria are presented. Bars without a common lowercase letter within a given survey differ, P , 0.05 (adjusted by using
Bonferroni correction). -CRP+AGP, adjusting for C-reactive protein and a-1-acid glycoprotein; -CRP+AGP+malaria, adjusting for C-reactive protein,
a-1-acid glycoprotein, and malaria.
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The ICF approach compared with the TCF or BCF approach
has the advantage of using the inflammation profile that is specific
to the data being adjusted. However, the precision of the ICF
approach is lower because the estimated prevalence of depleted
iron stores is based on the sample size of the reference group.
Nevertheless, only in circumstances when the sample size is not
sufficient to calculate a reliable ICF, an external CF should be
considered. In our analysis, the BCFs were lower in children than
in women. We suggest the use of the age-specific BCF instead of
the TCF that was derived from a previous meta-analysis, which
combined pregnant and nonpregnant women, men, children, and
HIV-positive adults (14).
We showed that the IRC approach had promise because it
better reflected the relation of ferritin concentrations with in-
flammation than the categorical approaches. Unlike in our study,
in which we showed larger changes in the estimated prevalence of
depleted iron stores after making IRC adjustments, other authors
showed limited differences between a regression and categorical
approach (16). These disparate results were likely due to previous
studies having applied adjustments only to individuals above the
cutoffs for CRP and AGP (16). We also showed that there was a
high degree of variability in the strength of the linear relation
(e.g., slopes) between ferritin and CRP and AGP across surveys,
and thus, internal slopes (i.e., ICF approach) should be used
instead of an external slope (i.e., BRC approach). The variation in
slopes across surveys necessitates further investigations to
identify potential modifiers of the ferritin–CRP-AGP relation in
particular the examination of differential effects by the type of
infection or inflammatory event.
We showed a stronger relation between inflammatory and
ferritin biomarkers in children than in women, which translated
into a greater increase in the estimated prevalence of depleted
iron stores in children when adjusted for inflammation. This
result may be indicative of differences in the response of ferritin
to an inflammatory event across the life cycle. Although this
hypothesis needs to be further explored, there has been sup-
porting evidence of age-specific differences when it comes to iron
metabolism (33), malaria (34), and pharmacokinetics (35).
The principal limitations of this study are the selection of data
sets on the basis of convenience (i.e., the availability of data from
BRINDA partners), the cross-sectional nature of the data, and the
absence of a gold-standard measure of iron status. With the use of
the BRINDA database, we were unable to determine whether
CRP and AGP incompletely capture the relation between ferritin
and inflammation or, alternatively, whether the adjustment ap-
proaches overadjust ferritin concentrations on the basis of a third
unknown confounder. A comparison of adjustment approaches
against a gold standard (e.g., bone marrow iron) and the use of
longitudinal data would further contribute to the evidence.
An exploration of the potential utility of other iron biomarkers
that are less affected by inflammation and infections would be
worthwhile. One such biomarker, soluble transferrin receptor, was
also shown to be influenced by inflammation and infections both
individually and as part of the body iron equation with the use of a
similar adjustment approach (36, 37). In addition, ferritin may also
be elevated in the presence of genetic disorders (38) and obesity
(39), and adjustments for these factors should be further studied.
In conclusion, the accurate assessment of iron status is critical to
guide policy and program decisions. This study is meant as a step
forward in identifying approaches to adjust ferritin concentrations in
populations with high levels of inflammation. Our findings lend
support for the use of the IRC approach. The use of this type of
approach is not new to the field and has been widely adopted to
adjust hemoglobin concentrations for altitude (40). However, the use
of the IRC approach often results in a substantial increase in the
estimated prevalence of depleted iron stores, which, in some cases,
has been by a magnitude of 2- to 3-fold. Therefore, it will be
important to describe the IRC approach to decision-makers or other
audiences without an epidemiologic background to facilitate its use.
The development of an automatic macro would also increase the
usability of the IRC approach. This study contributes to the evidence
on how to adjust ferritin concentrations for inflammation.
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